Genetic Other Current Liab vs Common Stock Analysis

GTG Stock

0.04 0.00 0.00%

Genetic Technologies financial indicator trend analysis is much more than just examining Genetic Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genetic Technologies is a good investment. Please check the relationship between Genetic Technologies Other Current Liab and its Common Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Other Current Liab vs Common Stock

Other Current Liab vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genetic Technologies Other Current Liab account and Common Stock. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Genetic Technologies' Other Current Liab and Common Stock is -0.24. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Common Stock in the same time period over historical financial statements of Genetic Technologies, assuming nothing else is changed. The correlation between historical values of Genetic Technologies' Other Current Liab and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Genetic Technologies are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Other Current Liab i.e., Genetic Technologies' Other Current Liab and Common Stock go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Current Liab

Common Stock

Most indicators from Genetic Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genetic Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Genetic Technologies' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is expected to grow at the current pace this year, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2025.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	18.1M	3.9M	3.5M	3.3M
Cost Of Revenue	4.3M	3.8M	3.4M	1.8M

Total Operating Expenses Cost Of Revenue

Genetic Technologies fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Good Will	Other Current Assets	Short Term Debt
Total Assets		0.17	-0.1	0.98	0.83	-0.9	-0.05	-0.35	0.91	0.21	-0.61	0.91	-0.07	0.21	-0.12	-0.07	-0.31	-0.15	0.33	0.94	0.17	0.21	-0.39	0.01	0.04	-0.44
Other Current Liab	0.17		0.48	0.06	0.53	0.19	0.3	0.31	-0.18	0.81	-0.34	-0.18	0.11	-0.29	0.25	0.23	0.0	0.57	0.31	-0.14	-0.24	0.33	0.49	-0.01	-0.07	-0.16
Total Current Liabilities	-0.1	0.48		-0.26	0.18	0.37	-0.52	0.93	-0.33	0.49	-0.11	-0.33	0.69	0.43	-0.21	-0.19	-0.5	0.88	0.79	-0.26	0.56	0.12	0.29	-0.36	0.18	0.62
Total Stockholder Equity	0.98	0.06	-0.26		0.75	-0.94	0.03	-0.5	0.94	0.12	-0.57	0.94	-0.21	0.16	-0.06	-0.03	-0.22	-0.33	0.19	0.95	0.09	0.17	-0.47	0.09	0.01	-0.53
Property Plant And Equipment Net	0.83	0.53	0.18	0.75		-0.58	-0.04	-0.1	0.59	0.55	-0.66	0.6	0.1	0.12	-0.07	-0.05	-0.35	0.19	0.52	0.64	0.12	0.36	-0.09	-0.07	0.03	-0.35
Net Debt	-0.9	0.19	0.37	-0.94	-0.58		0.12	0.53	-1.0	0.18	0.5	-1.0	0.25	-0.32	0.27	0.22	0.15	0.42	-0.07	-0.98	-0.22	0.08	0.48	0.03	-0.02	0.52
Retained Earnings	-0.05	0.3	-0.52	0.03	-0.04	0.12		-0.52	-0.15	0.23	0.22	-0.15	-0.5	-0.89	0.77	0.71	0.55	-0.38	-0.62	-0.15	-0.92	0.36	0.07	0.6	-0.36	-0.52
Accounts Payable	-0.35	0.31	0.93	-0.5	-0.1	0.53	-0.52		-0.49	0.24	0.15	-0.5	0.75	0.39	-0.22	-0.17	-0.4	0.87	0.63	-0.43	0.52	0.05	0.34	-0.31	0.06	0.72
Cash	0.91	-0.18	-0.33	0.94	0.59	-1.0	-0.15	-0.49		-0.19	-0.5	1.0	-0.21	0.34	-0.3	-0.25	-0.18	-0.35	0.1	0.99	0.25	-0.08	-0.44	-0.06	0.04	-0.5
Non Current Assets Total	0.21	0.81	0.49	0.12	0.55	0.18	0.23	0.24	-0.19		-0.39	-0.19	0.22	-0.28	0.3	0.21	-0.17	0.4	0.43	-0.14	-0.19	0.47	0.18	-0.04	-0.02	0.04
Non Currrent Assets Other	-0.61	-0.34	-0.11	-0.57	-0.66	0.5	0.22	0.15	-0.5	-0.39		-0.51	-0.04	-0.28	0.34	0.41	0.38	-0.09	-0.38	-0.48	-0.26	0.12	-0.1	0.43	-0.01	0.27
Cash And Short Term Investments	0.91	-0.18	-0.33	0.94	0.6	-1.0	-0.15	-0.5	1.0	-0.19	-0.51		-0.21	0.34	-0.3	-0.25	-0.17	-0.35	0.09	0.99	0.25	-0.08	-0.44	-0.07	0.04	-0.5
Net Receivables	-0.07	0.11	0.69	-0.21	0.1	0.25	-0.5	0.75	-0.21	0.22	-0.04	-0.21		0.29	-0.21	-0.18	-0.66	0.61	0.67	-0.12	0.43	0.32	0.08	-0.28	-0.24	0.8
Common Stock Total Equity	0.21	-0.29	0.43	0.16	0.12	-0.32	-0.89	0.39	0.34	-0.28	-0.28	0.34	0.29		-0.78	-0.73	-0.39	0.28	0.5	0.32	0.98	-0.52	-0.1	-0.58	0.3	0.25
Common Stock Shares Outstanding	-0.12	0.25	-0.21	-0.06	-0.07	0.27	0.77	-0.22	-0.3	0.3	0.34	-0.3	-0.21	-0.78		0.98	0.09	-0.24	-0.2	-0.22	-0.71	0.73	-0.14	0.88	-0.23	-0.12
Inventory	-0.07	0.23	-0.19	-0.03	-0.05	0.22	0.71	-0.17	-0.25	0.21	0.41	-0.25	-0.18	-0.73	0.98		0.06	-0.2	-0.15	-0.15	-0.66	0.76	-0.2	0.94	-0.19	-0.13
Other Stockholder Equity	-0.31	0.0	-0.5	-0.22	-0.35	0.15	0.55	-0.4	-0.18	-0.17	0.38	-0.17	-0.66	-0.39	0.09	0.06		-0.37	-0.85	-0.28	-0.53	-0.42	0.15	0.07	-0.15	-0.56
Total Liab	-0.15	0.57	0.88	-0.33	0.19	0.42	-0.38	0.87	-0.35	0.4	-0.09	-0.35	0.61	0.28	-0.24	-0.2	-0.37		0.63	-0.3	0.39	0.06	0.54	-0.4	0.17	0.48
Property Plant And Equipment Gross	0.33	0.31	0.79	0.19	0.52	-0.07	-0.62	0.63	0.1	0.43	-0.38	0.09	0.67	0.5	-0.2	-0.15	-0.85	0.63		0.2	0.64	0.36	-0.09	-0.21	0.29	0.5
Total Current Assets	0.94	-0.14	-0.26	0.95	0.64	-0.98	-0.15	-0.43	0.99	-0.14	-0.48	0.99	-0.12	0.32	-0.22	-0.15	-0.28	-0.3	0.2		0.26	0.06	-0.49	0.02	0.05	-0.43
Common Stock	0.17	-0.24	0.56	0.09	0.12	-0.22	-0.92	0.52	0.25	-0.19	-0.26	0.25	0.43	0.98	-0.71	-0.66	-0.53	0.39	0.64	0.26		-0.38	-0.1	-0.55	0.33	0.41
Property Plant Equipment	0.21	0.33	0.12	0.17	0.36	0.08	0.36	0.05	-0.08	0.47	0.12	-0.08	0.32	-0.52	0.73	0.76	-0.42	0.06	0.36	0.06	-0.38		-0.25	0.65	-0.18	0.18
Short Long Term Debt Total	-0.39	0.49	0.29	-0.47	-0.09	0.48	0.07	0.34	-0.44	0.18	-0.1	-0.44	0.08	-0.1	-0.14	-0.2	0.15	0.54	-0.09	-0.49	-0.1	-0.25		-0.38	-0.06	0.09
Good Will	0.01	-0.01	-0.36	0.09	-0.07	0.03	0.6	-0.31	-0.06	-0.04	0.43	-0.07	-0.28	-0.58	0.88	0.94	0.07	-0.4	-0.21	0.02	-0.55	0.65	-0.38		-0.18	-0.23
Other Current Assets	0.04	-0.07	0.18	0.01	0.03	-0.02	-0.36	0.06	0.04	-0.02	-0.01	0.04	-0.24	0.3	-0.23	-0.19	-0.15	0.17	0.29	0.05	0.33	-0.18	-0.06	-0.18		0.06
Short Term Debt	-0.44	-0.16	0.62	-0.53	-0.35	0.52	-0.52	0.72	-0.5	0.04	0.27	-0.5	0.8	0.25	-0.12	-0.13	-0.56	0.48	0.5	-0.43	0.41	0.18	0.09	-0.23	0.06

Click cells to compare fundamentals

Genetic Technologies Account Relationship Matchups

Genetic Technologies fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	23.0M	20.8M	14.9M	6.2M	5.6M	5.3M
Other Current Liab	955.5K	1.6M	1.3M	1.1M	1.0M	901.4K
Total Current Liabilities	1.4M	3.8M	3.3M	4.2M	3.8M	2.0M
Total Stockholder Equity	21.5M	16.4M	11.2M	1.8M	1.6M	1.6M
Property Plant And Equipment Net	637.7K	953.3K	599.2K	264.5K	238.0K	226.1K
Net Debt	(20.7M)	(11.1M)	(7.3M)	(145.4K)	(130.9K)	(137.4K)
Retained Earnings	(143.1M)	(150.2M)	(156.7M)	(166.4M)	(149.7M)	(142.3M)
Accounts Payable	269.7K	1.2M	838.0K	1.5M	1.3M	789.6K
Cash	20.9M	11.7M	7.9M	1.0M	1.2M	1.1M
Non Current Assets Total	735.6K	6.1M	4.2M	2.5M	2.2M	2.1M
Non Currrent Assets Other	(9.5M)	(6.1M)	(4.2M)	81.7K	73.5K	77.2K
Cash And Short Term Investments	20.9M	11.7M	7.9M	1.0M	1.2M	1.1M
Net Receivables	1.1M	2.4M	191.9K	2.1M	2.4M	2.6M
Common Stock Shares Outstanding	85.4M	92.2M	101.4M	132.2M	119.0M	113.0M
Liabilities And Stockholders Equity	23.0M	20.8M	14.9M	6.2M	5.6M	5.3M
Inventory	76.9K	398.2K	325.9K	206.5K	185.8K	176.5K
Other Stockholder Equity	1.2M	(10.5M)	(4.9M)	(4.6M)	(4.2M)	(4.0M)
Total Liab	1.4M	4.4M	3.7M	4.4M	3.9M	2.3M
Property Plant And Equipment Gross	1.3M	1.9M	1.8M	1.5M	1.4M	946.1K
Total Current Assets	22.2M	14.7M	10.5M	3.7M	4.2M	4.0M
Common Stock	153.6M	155.1M	161.3M	163.8M	188.4M	99.3M
Property Plant Equipment	440.2K	637.7K	953.3K	599.2K	539.3K	876.6K
Short Long Term Debt Total	204.0K	652.5K	532.9K	875.2K	787.7K	509.7K
Other Current Assets	182.6K	18.2K	2.1M	341.7K	393.0K	461.4K
Short Term Debt	179.6K	264.1K	303.6K	852.3K	980.1K	1.0M
Short Term Investments	1.9K	13.3K	17.4K	18.8K	16.9K	16.1K
Non Current Liabilities Total	33.3K	558.9K	381.6K	160.6K	144.6K	137.4K
Accumulated Other Comprehensive Income	11.0M	11.5M	6.5M	4.4M	5.0M	4.3M
Current Deferred Revenue	635.0	814.2K	849.2K	741.6K	852.9K	895.5K
Other Liab	979.2K	8.9K	170.5K	152.3K	175.2K	133.1K
Net Tangible Assets	13.0M	21.5M	11.3M	7.5M	8.7M	11.1M
Long Term Debt Total	240.9K	24.4K	388.4K	229.3K	263.7K	138.8K
Net Invested Capital	21.5M	16.4M	11.2M	2.5M	2.8M	2.7M
Net Working Capital	20.8M	10.9M	7.2M	(500.1K)	(450.1K)	(427.6K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC